| Identification | Back Directory | [Name]
9H-Purine,6-(4-morpholinyl)-9-b-D-ribofuranosyl- | [CAS]
52940-48-4 | [Synonyms]
6-(4-Morpholino)purine riboside
6-(4-Morpholino)-9-(b-D-ribofuranosyl)-9H-purine
9H-Purine,6-(4-morpholinyl)-9-b-D-ribofuranosyl-
9H-Purine, 6-(4-morpholinyl)-9-β-D-ribofuranosyl-
6-(4-Morpholino)-9-(beta-D-ribofuranosyl)-9H-purine | [Molecular Formula]
C14H19N5O5 | [MDL Number]
MFCD30718538 | [MOL File]
52940-48-4.mol | [Molecular Weight]
337.33 |
| Hazard Information | Back Directory | [Uses]
6-(4-Morpholinyl)-9-β-D-ribofuranosyl-9H-purine is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | [References]
[1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 |
|
| Company Name: |
NewCan Biotech Limited
|
| Telephone: |
+86-571-86912261 19975279805 |
| Website: |
https://www.newcanbio.com/ |
|